Aligos Therapeutics Inc Ordinary Shares (NASDAQ:ALGS)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ALGS

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ALGS

  • Market Cap$948.500m
  • SymbolNASDAQ:ALGS
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS01626L1052

Company Profile

Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Latest ALGS news

Currently there for this company. Visit our news hub for other news .